JULIE NATANZON: Open Payments
NPI 1952345779 · MEADOWBROOK, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$676 in 17 payments from 8 companies in 2025. Trend: 2023 $284 · 2024 $451 · 2025 $676
Food & beverage: $676
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | 4 | $198 |
| ABBVIE INC. | 1 | $124 |
| E.R. Squibb & Sons, L.L.C. | 1 | $120 |
| PFIZER INC. | 4 | $81 |
| Boston Scientific Corporation | 2 | $60 |
| Lilly USA, LLC | 2 | $37 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $32 |
| Azurity Pharmaceuticals, Inc. | 1 | $25 |
Products named: ULTOMIRIS, QULIPTA, ZEPOSIA, NURTEC ODT, General - DBS, KISUNLA, JOURNAVX, HORIZANT.
Industry payments across PA — which companies pay providers there.
